Indeed, GLP-1RAs have evolved over time such that the frequency of dosing has decreased from twice-daily (exenatide, BD) [65], to once-daily (liraglutide, lixisenatide) [66, 67] to once-weekly (dulaglutide, exenatide QW, semaglutide) [5, 6], suggesting a higher adherence potential for the longer-acting agents (Table 2)
Glutathione is a powerful antioxidant that helps protect cells from damage caused by free radicals, while collagen is essential for maintaining healthy skin, hair, and nails
After a year being off the medication only people who lost 15% or more of their body weight still retained meaningful weight loss. Its not just weight
Tsomaia, N
GLP-1 therapy may be appropriate for adults with a BMI of 27 or above, or 25 and above with a weight-related comorbidity, as well as those pursuing metabolic optimization under appropriate clinical criteria